Observational studyThe journal of extra-corporeal technology2025
Tranexamic acid does not have a dose-dependent effect on postoperative delirium after cardiac surgery - a retrospective cohort study.
Observational study in The journal of extra-corporeal technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative delirium, regularly seen after cardiac surgery, is challenging. It has significant implications for healthcare resources and significant implications for individual patients and their families. Although the exact mechanisms are not understood, there is emerging evidence that blood-brain-barrier disruption and neuroinflammation may play a role in developing postoperative delirium. Tranexamic acid, frequently used in cardiac surgery for its transfusion-sparing effect, has recently been shown to ameliorate neuroinflammation and stabilise the blood-brain barrier. This study investigates if there is a dose-dependent effect of tranexamic acid on developing postoperative delirium after cardiac surgery on cardiopulmonary bypass.
methods5525 patients were included in this retrospective, observational database study. Patients were divided into three groups, depending on the dose of tranexamic acid they had received before heparinisation (Group A (n = 1780) up to 22 mg/kg, Group B (n = 2130) 22.01 - 27 mg/kg, and Group C (n = 1615) 27.01 mg/kg or more). All three doses are clinically relevant and seen regularly. The presence of postoperative delirium was defined by at least one "CAM-ICU positive" entry in the patient's medical record.
resultsThere was no statistically significant difference between the three groups in the incidence of postoperative delirium. The percentage of CAM-ICU-positive patients in each group was in keeping with the overall cohort (Overall = 18%, Group A = 18%, Group B = 17%, Group C = 20%, p = 0.25).
conclusionThe results do not support the theory that tranexamic acid given in the higher clinically acceptable dose range decreases the incidence of postoperative delirium after cardiac surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.